nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age and the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: Was Tacitus Wrong?
|
Mehta, Jayesh |
|
2011 |
17 |
12 |
p. 1878- 1 p. |
artikel |
2 |
Can G-CSF Cause Leukemia in Hematopoietic Stem Cell Donors?
|
Avalos, Belinda R. |
|
2011 |
17 |
12 |
p. 1739-1746 8 p. |
artikel |
3 |
Comorbidities and Outcomes: Advancing the Field Comes at a Price
|
Sorror, Mohamed L. |
|
2011 |
17 |
12 |
p. 1721-1723 3 p. |
artikel |
4 |
Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Age 60-70 Years with Acute Myelogenous Leukemia in First Remission
|
Farag, Sherif S. |
|
2011 |
17 |
12 |
p. 1796-1803 8 p. |
artikel |
5 |
Cord Blood Transplantation from Unrelated Donors for Children with Acute Lymphoblastic Leukemia in Japan: The Impact of Methotrexate on Clinical Outcomes
|
Kato, Koji |
|
2011 |
17 |
12 |
p. 1814-1821 8 p. |
artikel |
6 |
Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
|
Passweg, Jakob R. |
|
2011 |
17 |
12 |
p. 1869-1873 5 p. |
artikel |
7 |
Early and Late Extensive Chronic Graft-versus-Host Disease in Children Is Characterized by Different Th1/Th2 Cytokine Profiles: Findings of the Children's Oncology Group Study ASCT0031
|
Rozmus, Jacob |
|
2011 |
17 |
12 |
p. 1804-1813 10 p. |
artikel |
8 |
Editorial Board
|
|
|
2011 |
17 |
12 |
p. A2- 1 p. |
artikel |
9 |
Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
|
Vogl, Dan T. |
|
2011 |
17 |
12 |
p. 1765-1774 10 p. |
artikel |
10 |
Genomic Aberrations and Survival of Patients with Light-Chain-Only Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
|
Jiang, Nan |
|
2011 |
17 |
12 |
p. 1790-1795 6 p. |
artikel |
11 |
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease
|
Tawara, Isao |
|
2011 |
17 |
12 |
p. 1747-1753 7 p. |
artikel |
12 |
Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
|
Barao, Isabel |
|
2011 |
17 |
12 |
p. 1754-1764 11 p. |
artikel |
13 |
Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome
|
McIver, Zachariah A. |
|
2011 |
17 |
12 |
p. 1846-1854 9 p. |
artikel |
14 |
Malignancies after Hematopoietic Cell Transplantation for Primary Immune Deficiencies: A Report from the Center for International Blood and Marrow Transplant Research
|
Kamani, Naynesh R. |
|
2011 |
17 |
12 |
p. 1783-1789 7 p. |
artikel |
15 |
Masthead (Purpose and Scope)
|
|
|
2011 |
17 |
12 |
p. A1- 1 p. |
artikel |
16 |
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks
|
Dvorak, Christopher C. |
|
2011 |
17 |
12 |
p. 1725-1738 14 p. |
artikel |
17 |
Officers and Directors of ASBMT
|
|
|
2011 |
17 |
12 |
p. A4- 1 p. |
artikel |
18 |
Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission
|
Nemecek, Eneida R. |
|
2011 |
17 |
12 |
p. 1833-1840 8 p. |
artikel |
19 |
Platelet Recovery Before Allogeneic Stem Cell Transplantation Predicts Posttransplantation Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
|
Alatrash, Gheath |
|
2011 |
17 |
12 |
p. 1841-1845 5 p. |
artikel |
20 |
Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study
|
Greinix, Hildegard T. |
|
2011 |
17 |
12 |
p. 1775-1782 8 p. |
artikel |
21 |
Reduced-Intensity Allogeneic Hematopoietic Transplantation Should Be Considered a Standard of Care for Older Patients with Acute Myeloid Leukemia
|
Champlin, Richard |
|
2011 |
17 |
12 |
p. 1723-1724 2 p. |
artikel |
22 |
Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies
|
Mielke, Stephan |
|
2011 |
17 |
12 |
p. 1855-1861 7 p. |
artikel |
23 |
Table of Contents
|
|
|
2011 |
17 |
12 |
p. A5-A8 nvt p. |
artikel |
24 |
The Hematopoietic Cell Transplantation-Specific Comorbidity Index Fails to Predict Outcomes in High-Risk AML Patients Undergoing Allogeneic Transplantation—Investigation of Potential Limitations of the Index
|
Birninger, Nicole |
|
2011 |
17 |
12 |
p. 1822-1832 11 p. |
artikel |
25 |
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
|
Drobyski, William R. |
|
2011 |
17 |
12 |
p. 1862-1868 7 p. |
artikel |
26 |
Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib
|
Sharma, Manish |
|
2011 |
17 |
12 |
p. 1874-1877 4 p. |
artikel |